Stephen Weis, DO

Research output

Research output per year 1988 2000 2001 2002 2003 2005 2006 2007 2008 2009 2010 2011 2015 2022

• 89 Article
• 5 Letter
• 3 Editorial
• 3 Review article
• 4 More
  • 1 Chapter
  • 1 Conference contribution
  • 1 Comment/debate
  • 1 Short survey

Research output per year

Research output per year

Search results

• Effect of pedal rate on cardiorespiratory responses during continuous exercise

  Hagan, R. D., Weis, S. E. & Raven, P. B., Oct 1992, In: Medicine and Science in Sports and Exercise. 24, 10, p. 1088-1095 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Foot 100%
  • Heart Rate 57%
  • Ventilation 46%
  • Ergometry 35%
  • Lactic Acid 23%

• Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART Study

  The Strategies for Management of Antiretroviral Therapy (SMART) Study Group, 15 Apr 2008, In: Journal of Infectious Diseases. 197, 8, p. 1133-1144 12 p.

  Research output: Contribution to journal › Article › peer-review

  • CD4 Lymphocyte Count 100%
  • HIV 33%
  • Randomized Controlled Trials 33%
  • Drug Therapy 28%
  • Therapeutics 24%

• Inferior clinical outcome of the CD4⁺ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4⁺ cell counts and HIV RNA levels during follow-up

  The Strategies for Management of Antiretroviral Therapy (SMART) Study Group, 15 Apr 2008, In: Journal of Infectious Diseases. 197, 8, p. 1145-1155 11 p.

  Research output: Contribution to journal › Article › peer-review

  • CD4 Lymphocyte Count 100%
  • RNA 68%
  • HIV 67%
  • Pharmaceutical Preparations 29%
  • Virus Replication 28%

• Erratum: Treatment for Preventing Tuberculosis in Children and Adolescents : Ed Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid (JAMA Pediatrics (2015) 169:3 (247-255))

  Villarino, M. E., Scott, N. A. & Weis, S. E., 1 Sep 2015, In: JAMA Pediatrics. 169, 9, p. 878 1 p.

  Research output: Contribution to journal › Comment/debate

• Transmission of drug-resistant tuberculosis in Texas and Mexico

  Quitugua, T. N., Seaworth, B. J., Weis, S. E., Taylor, J. P., Gillette, J. S., Rosas, I. I., Jost, K. C., Magee, D. M. & Cox, R. A., 1 Aug 2002, In: Journal of Clinical Microbiology. 40, 8, p. 2716-2724 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Multidrug-Resistant Tuberculosis 100%
  • Mexico 87%
  • Pharmaceutical Preparations 34%
  • Genotype 17%
  • Cluster Analysis 14%

• Mortality hazard and survival after tuberculosis treatment

  Miller, T. L., Wilson, F. A., Pang, J. W., Beavers, S., Hoger, S., Sharnprapai, S., Pagaoa, M., Katz, D. J. & Weis, S. E., 1 May 2015, In: American journal of public health. 105, 5, p. 930-937 8 p.

  Research output: Contribution to journal › Article › peer-review

  • contagious disease 100%
  • mortality 85%
  • Tuberculosis 84%
  • Survival 56%
  • Mortality 51%

• The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

  The International HIV Controllers Study, 10 Dec 2010, In: Science. 330, 6010, p. 1551-1557 7 p.

  Research output: Contribution to journal › Article › peer-review

  • HLA Antigens 100%
  • HIV-1 84%
  • Peptides 62%
  • Major Histocompatibility Complex 39%
  • Single Nucleotide Polymorphism 32%

• Evaluation of gemfibrozil therapy: Predictive response from lipoprotein subfraction analysis

  Loney, W. W., Kudchodkar, B. J., Weis, S., Clearfield, M. B., Shores, J. & Lacko, A. G., 1997, In: American Journal of Therapeutics. 4, 9-10, p. 301-309 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Gemfibrozil 100%
  • Lipoproteins 64%
  • HDL Cholesterol 60%
  • Triglycerides 31%
  • Lipids 18%

• The efficacy of gemfibrozil therapy for raising high density lipoprotein levels

  Weis, S., Kudchodkar, B. J., Clearfield, M. B. & Lacko, A. G., 1 Jan 1992, In: Artery. 19, 6, p. 353-367 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Gemfibrozil 100%
  • HDL Lipoproteins 71%
  • HDL Cholesterol 40%
  • Serum 30%
  • Body Weight Changes 27%

• Decrease in high density lipoprotein cholesterol (HDL-C) levels following gemfibrozil therapy

  Lacko, A. G., Kudchodkar, B. J., Loney, W. W., Clearfield, M. B. & Weis, S., 1998, In: Clinical Chemistry and Laboratory Medicine. 36, 6, p. 389-392 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Gemfibrozil 100%
  • High-Density Lipoprotein Cholesterol 98%
  • HDL Cholesterol 56%
  • High-Density Lipoprotein 26%
  • HDL Lipoproteins 16%

• Personal and societal health quality lost to tuberculosis

  Miller, T. L., McNabb, S. J. N., Hilsenrath, P., Pasipanodya, J. & Weis, S. E., 8 Apr 2009, In: PLoS ONE. 4, 4, e5080.

  Research output: Contribution to journal › Article › peer-review

  • tuberculosis 100%
  • quality-adjusted life year 99%
  • Quality-Adjusted Life Years 76%
  • Tuberculosis 72%
  • Health 43%

• Air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS): Efficacy and tolerability of long-term treatment with lovastatin in women

  Clearfield, M., Downs, J. R., Weis, S., Whitney, E. J., Kruyer, W., Shapiro, D. R., Stein, E. A., Langendorfer, A., Beere, P. A. & Gotto, A. M., 1 Dec 2001, In: Journal of Women’s Health and Gender-Based Medicine. 10, 10, p. 971-981 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Lovastatin 100%
  • Coronary Artery Disease 62%
  • Air 60%
  • LDL Cholesterol 18%
  • HDL Cholesterol 18%

• Production of interleukin-18 in human tuberculosis

  Vankayalapati, R., Wizel, B., Weis, S. E., Samten, B., Girard, W. M. & Barnes, P. F., 2000, In: Journal of Infectious Diseases. 182, 1, p. 234-239 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Interleukin-18 100%
  • Tuberculosis 70%
  • Interferons 34%
  • Mycobacterium tuberculosis 27%
  • Blood Cells 23%

• Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States

  Yang, Z., Barnes, P. F., Chaves, F., Eisenach, K. D., Weis, S. E., Bates, J. H. & Cave, M. D., Apr 1998, In: Journal of Clinical Microbiology. 36, 4, p. 1003-1007 5 p.

  Research output: Contribution to journal › Article › peer-review

  • DNA Fingerprinting 100%
  • Dermatoglyphics 93%
  • Mycobacterium tuberculosis 77%
  • Tuberculosis 32%
  • Geographic Locations 25%

• Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-γ release assays in persons with suspected tuberculosis

  Mazurek, G. H., Weis, S. E., Moonan, P. K., Daley, C. L., Bernardo, J., Lardizabal, A. A., Reves, R. R., Toney, S. R., Daniels, L. J. & LoBue, P. A., 2007, In: Clinical Infectious Diseases. 45, 7, p. 837-845 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Tuberculin Test 100%
  • Skin Tests 80%
  • Interferons 72%
  • Tuberculosis 65%
  • Confidence Intervals 23%

• Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

  D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups, 1 Mar 2015, In: PLoS Medicine. 12, 3, e1001809.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Renal Insufficiency 100%
  • HIV Infections 96%
  • Atazanavir Sulfate 35%
  • Ritonavir 30%
  • Glomerular Filtration Rate 23%

• Design and rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

  Downs, J. R., Beere, P. A., Whitney, E., Clearfield, M., Weis, S., Rochen, J., Stein, E. A., Shapiro, D. R., Langendorfer, A. & Gotto, A. M., 1 Aug 1997, In: American Journal of Cardiology. 80, 3, p. 287-293 7 p.

  Research output: Contribution to journal › Article › peer-review

  • LDL Cholesterol 100%
  • Coronary Artery Disease 91%
  • Air 88%
  • Lovastatin 73%
  • Primary Prevention 57%

• Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy

  Weiner, M., Bock, N., Peloquin, C. A., Burman, W. J., Khan, A., Vernon, A., Zhao, Z., Weis, S., Sterling, T. R., Hayden, K. & Goldberg, S., 1 Jun 2004, In: American Journal of Respiratory and Critical Care Medicine. 169, 11, p. 1191-1197 7 p.

  Research output: Contribution to journal › Article › peer-review

  • rifapentine 100%
  • Tuberculosis 48%
  • Pharmacokinetics 44%
  • Therapeutics 9%
  • Isoniazid 9%

• Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis

  Moonan, P. K. & Weis, S. E., 1 Oct 2013, In: Clinical Infectious Diseases. 57, 7, p. 1062-1063 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Early clinical experience with networked system for promoting patient self-management

  Au-Yeung, K. Y., Moon, G. D., Robertson, T. L., DiCarlo, L. A., Epstein, M. S., Weis, S. E., Reves, R. R. & Engel, G., Jul 2011, In: American Journal of Managed Care. 17, 7, p. e277-e287

  Research output: Contribution to journal › Article › peer-review

  • Clinical experience 100%
  • Self-Management 93%
  • Eating 43%
  • management 41%
  • Sphygmomanometers 40%

• Universal HIV screening at a major metropolitan TB clinic: HIV prevalence and high-risk behaviors among TB patients

  Weis, S. E., Foresman, B., Cook, P. E. & Matty, K. J., Jan 1999, In: American journal of public health. 89, 1, p. 73-75 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Risk-Taking 100%
  • risk behavior 99%
  • contagious disease 95%
  • Tuberculosis 80%
  • HIV 67%

• Tuberculosis in the foreign-born population of Tarrant County, Texas by immigration status

  Weis, S. E., Moonan, P. K., Pogoda, J. M., Turk, L., King, B., Freeman-Thompson, S. & Burgess, G., 15 Sep 2001, In: American Journal of Respiratory and Critical Care Medicine. 164, 6, p. 953-957 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Emigration and Immigration 100%
  • Tuberculosis 69%
  • Population 33%
  • Hospitalization 31%
  • HIV 29%

• Effectiveness of an intervention to overcome influenza vaccine hesitancy in specialty clinic patients

  Webb, N. J., Lindsley, J., Stockbridge, E. L., Workman, A., Reynolds, C. D., Miller, T. L., Charles, J., Carletti, M., Casperson, S. & Weis, S., 29 Jul 2022, In: Medicine (United States). 101, 30, p. E29786

  Research output: Contribution to journal › Article › peer-review

  • Influenza Vaccines 100%
  • Human Influenza 80%
  • Immunization 57%
  • Vaccination 54%
  • Immunosuppressive Agents 32%

• The Effect of Offering Pneumococcal Vaccines During Specialty Care on Vaccination Rates in Patients Receiving Immunosuppressive Therapy

  Lindsley, J., Webb, N., Workman, A., Miller, T. L., Stockbridge, E. L., Charles, J., Carletti, M., Casperson, S. & Weis, S., 21 May 2021, In: SKIN: Journal of Cutaneous Medicine. 5, 3, p. 250-264 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Pneumococcal Vaccines 100%
  • Immunization 67%
  • Immunosuppressive Agents 66%
  • Vaccination 64%
  • Quality Improvement 42%

• Comprehensive cost description of tuberculosis care [2] (multiple letters)

  Weis, S. E., Miller, T. L., Hilsenrath, P. E., Moonan, P. K., Rajbhandary, S. S., Marks, S. M. & Bock, N. N., Apr 2005, In: International Journal of Tuberculosis and Lung Disease. 9, 4, p. 467-469 3 p.

  Research output: Contribution to journal › Letter › peer-review